Atlas Logo
Scientific Evaluation of Supervised Injecting cohort (SEOSI)
BACK
Sample details

The SEOSI cohort was designed to evaluate the impact of the Safer Injection Facility Insite in Downtown Eastside, Vancouver, Canada. The study recruited a representative sample of intravenous drug users (IDUs) from Insite, aged 19 - 64 years, who generally resided in Vancouver, Canada. At baseline, over 1,000 people were included in the SEOSI cohort. Participants were interviewed at baseline and followed up at least once. Several sub-studies were conducted with various groups of SEOSI cohort participants.

Study design
Cohort

Number of participants at first data collection

1,065 (participants)

Age at first data collection

19 - 64 years (participants)

Participant year of birth

Varied (participants)

Participant sex
All

Representative sample at baseline?
Vancouver safer injection facilities (SIFs), known as InSite users.

Sample features

Adults
Older and elderly people
Substance users
Dataset details

Country

Canada

Year of first data collection

2003

Primary Institutions

British Columbia Centre on Substance Use (BCCSU)

Portland Hotel Society (PHS)

Providence Health Care (PHC)

University of British Columbia (UBC)

Vancouver Coastal Health

Links

bccsu.ca/seosi/

doi.org/10.1186/1477-7517-1-9

Funders

Canadian Institutes of Health Research (CIHR, Instituts de recherche en santé du Canada, IRSC)

Ongoing?
No

Data types collected

qualitativeData
dataLinkage
Quantitative data collection
  • Interview – face-to-face
  • Physical or biological assessment (e.g. blood, saliva, gait, grip strength, anthropometry)
  • Secondary data
Qualitative data collection
  • Interviews or focus groups
Neuroimaging data collection
  • None
Linked or secondary data
  • Healthcare data
Features

Engagement

  • None
  • Keywords

    Addiction
    Disease risk
    Disease transmission
    Drug testing
    Hepatitis
    Human immunodeficiency virus (HIV)
    Interventions
    Sub-studies
    Contact us

    |

    FAQS

    |

    Privacy

    |

    © 2024 Louise Arseneault

    Platform by Delosis